Interleukin-18 and IL-18BP in inflammatory dermatological diseases

Interleukin (IL)-18, an interferon-γ inducer, belongs to the IL-1 family of pleiotropic pro-inflammatory factors, and IL-18 binding protein (IL-18BP) is a native antagonist of IL-18 in vivo, regulating its activity. Moreover, IL-18 exerts an influential function in host innate and adaptive immunity,...

Full description

Bibliographic Details
Main Authors: Xiaoyun Wang, Lian Wang, Xiang Wen, Lu Zhang, Xian Jiang, Gu He
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.955369/full
_version_ 1828061717932802048
author Xiaoyun Wang
Xiaoyun Wang
Lian Wang
Xiang Wen
Lu Zhang
Xian Jiang
Xian Jiang
Gu He
Gu He
author_facet Xiaoyun Wang
Xiaoyun Wang
Lian Wang
Xiang Wen
Lu Zhang
Xian Jiang
Xian Jiang
Gu He
Gu He
author_sort Xiaoyun Wang
collection DOAJ
description Interleukin (IL)-18, an interferon-γ inducer, belongs to the IL-1 family of pleiotropic pro-inflammatory factors, and IL-18 binding protein (IL-18BP) is a native antagonist of IL-18 in vivo, regulating its activity. Moreover, IL-18 exerts an influential function in host innate and adaptive immunity, and IL-18BP has elevated levels of interferon-γ in diverse cells, suggesting that IL-18BP is a negative feedback inhibitor of IL-18-mediated immunity. Similar to IL-1β, the IL-18 cytokine is produced as an indolent precursor that requires further processing into an active cytokine by caspase-1 and mediating downstream signaling pathways through MyD88. IL-18 has been implicated to play a role in psoriasis, atopic dermatitis, rosacea, and bullous pemphigoid in human inflammatory skin diseases. Currently, IL-18BP is less explored in treating inflammatory skin diseases, while IL-18BP is being tested in clinical trials for other diseases. Thereby, IL-18BP is a prospective therapeutic target.
first_indexed 2024-04-10T22:18:09Z
format Article
id doaj.art-f9ce7f1c1cff41919a842ff48b31ff83
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-10T22:18:09Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-f9ce7f1c1cff41919a842ff48b31ff832023-01-18T07:04:59ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-01-011410.3389/fimmu.2023.955369955369Interleukin-18 and IL-18BP in inflammatory dermatological diseasesXiaoyun Wang0Xiaoyun Wang1Lian Wang2Xiang Wen3Lu Zhang4Xian Jiang5Xian Jiang6Gu He7Gu He8Department of Dermatology, West China Hospital, Sichuan University, Chengdu, ChinaLaboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-Related Molecular Network and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Dermatology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Dermatology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Dermatology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Dermatology, West China Hospital, Sichuan University, Chengdu, ChinaLaboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-Related Molecular Network and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Dermatology, West China Hospital, Sichuan University, Chengdu, ChinaLaboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-Related Molecular Network and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, ChinaInterleukin (IL)-18, an interferon-γ inducer, belongs to the IL-1 family of pleiotropic pro-inflammatory factors, and IL-18 binding protein (IL-18BP) is a native antagonist of IL-18 in vivo, regulating its activity. Moreover, IL-18 exerts an influential function in host innate and adaptive immunity, and IL-18BP has elevated levels of interferon-γ in diverse cells, suggesting that IL-18BP is a negative feedback inhibitor of IL-18-mediated immunity. Similar to IL-1β, the IL-18 cytokine is produced as an indolent precursor that requires further processing into an active cytokine by caspase-1 and mediating downstream signaling pathways through MyD88. IL-18 has been implicated to play a role in psoriasis, atopic dermatitis, rosacea, and bullous pemphigoid in human inflammatory skin diseases. Currently, IL-18BP is less explored in treating inflammatory skin diseases, while IL-18BP is being tested in clinical trials for other diseases. Thereby, IL-18BP is a prospective therapeutic target.https://www.frontiersin.org/articles/10.3389/fimmu.2023.955369/fullIL-18 binding proteinIL-18psoriasisatopic dermatitisrosaceabullous pemphigoid
spellingShingle Xiaoyun Wang
Xiaoyun Wang
Lian Wang
Xiang Wen
Lu Zhang
Xian Jiang
Xian Jiang
Gu He
Gu He
Interleukin-18 and IL-18BP in inflammatory dermatological diseases
Frontiers in Immunology
IL-18 binding protein
IL-18
psoriasis
atopic dermatitis
rosacea
bullous pemphigoid
title Interleukin-18 and IL-18BP in inflammatory dermatological diseases
title_full Interleukin-18 and IL-18BP in inflammatory dermatological diseases
title_fullStr Interleukin-18 and IL-18BP in inflammatory dermatological diseases
title_full_unstemmed Interleukin-18 and IL-18BP in inflammatory dermatological diseases
title_short Interleukin-18 and IL-18BP in inflammatory dermatological diseases
title_sort interleukin 18 and il 18bp in inflammatory dermatological diseases
topic IL-18 binding protein
IL-18
psoriasis
atopic dermatitis
rosacea
bullous pemphigoid
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.955369/full
work_keys_str_mv AT xiaoyunwang interleukin18andil18bpininflammatorydermatologicaldiseases
AT xiaoyunwang interleukin18andil18bpininflammatorydermatologicaldiseases
AT lianwang interleukin18andil18bpininflammatorydermatologicaldiseases
AT xiangwen interleukin18andil18bpininflammatorydermatologicaldiseases
AT luzhang interleukin18andil18bpininflammatorydermatologicaldiseases
AT xianjiang interleukin18andil18bpininflammatorydermatologicaldiseases
AT xianjiang interleukin18andil18bpininflammatorydermatologicaldiseases
AT guhe interleukin18andil18bpininflammatorydermatologicaldiseases
AT guhe interleukin18andil18bpininflammatorydermatologicaldiseases